Determination of plasma concentrations of epirubicin and its metabolites by high-performance liquid chromatography during a 96-h infusion in cancer chemotherapy
- 7 June 1996
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 681 (2), 323-329
- https://doi.org/10.1016/0378-4347(96)00030-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1993
- Solid-phase extraction and optimized separation of doxorubicin, epirubicin and their metabolites using reversed-phase high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1992
- Chromatographic analysis of anticancer drugsJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- Metabolism of epirubicin to glucuronides: relationship to the pharmacodynamics of the drugCancer Chemotherapy and Pharmacology, 1990
- Clinical and pharmacokinetic study of 96-h infusions of doxorubicin in advanced cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1989
- In Vitro Chemosensitivity Testing Using the Multicellular Tumor Spheroid ModelCancer Drug Delivery, 1987
- Metabolism of 4′-modified analogs of doxorubicin. Unique glucuronidation pathway for 4′-epidoxorubicinEuropean Journal of Cancer and Clinical Oncology, 1984
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981